Parameter | Estimate | Data | Source |
Population characteristics | |||
Mean age (SD) | 53.0 (13.5) | Triangular (35,53,85) | Goodacre et al8 |
% Male | 58.1% | n/N=1138/1958 | Goodacre et al8 |
MI prevalence | 7.0% | n/N=137/1958 | Goodacre et al8 |
Median (IQR) time delay (minutes) | 132 (80255) | _ | Goodacre et al8 |
1-year probabilities of death and non-fatal MI | |||
Death, treated MI | 11% | n/N=9/80 | Mills et al10 |
Death, untreated MI | 21% | n/N=19/90 | Mills et al10 |
Reinfarction, treated MI | 11% | n/N=9/80 | Mills et al10 |
Reinfarction, untreated MI | 29% | n/N=26/90 | Mills et al10 |
Parameter | Estimate | Distribution | Source |
Costs of tests, hospital stay and treatment | |||
Treatment of MI (index or reinfarction) | £3587 | Uniform (3000, 4000) | NHS reference costs14 |
Hospital stay (per hour) for testing | £22 | Uniform (20, 30) | NHS reference costs for general medical ward14 |
Troponin testing (per test) | £20 | Uniform (18, 25) | Goodacre et al8 |